FindTrial
Sign In

CRISPLD2 in the evaluation of the prognosis in sepsis

Prospective observational study on CRISPLD2 in the evaluation of the prognosis in sepsis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-11001244
Enrollment
Unknown
Registered
2011-03-29
Start date
2010-08-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Group A:Blood serum collection
Group B:Blood serum collection

Sponsors

Shanghai Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Have the following two or more than two signs: temperature beteen 36 to 38 degree C; heart rate> 90 beats / min; respiratory rate> 20 beats / min or PaCO2 12.0*10^9/L or 10%; 2. A clear or highly suspected infection focus.

Exclusion criteria

Exclusion criteria: 1. Aged <18 years; 2. Combined with HIV,blood tumor and acute infectious disease; 3. Patients or family members refuse the test; 4. Those have participated in other clinical trials; 5. Those that researchers believe not suitable for clinical trials.

Design outcomes

Primary

MeasureTime frame
procalcitonin;Prognosis;CRISPLD;—

Secondary

MeasureTime frame
c-reactive protein;Acute physiology and chronic health score;Sepsis-related organ dysfunction score;—

Countries

China

Contacts

Public ContactZhaofen Lin
linzhaofen@sina.com+86 13601605100

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026